The prevalence and risk of allergic rhinitis in psoriasis patients: a systematic review and meta-analysis
Issued Date
2025-12-01
Resource Type
eISSN
20452322
Scopus ID
2-s2.0-105000187550
Pubmed ID
40089525
Journal Title
Scientific Reports
Volume
15
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Scientific Reports Vol.15 No.1 (2025)
Suggested Citation
Untaaveesup S., Amnartpanich T., Leelakanok N., Owattanapanich W., Kantagowit P., Dendumrongsup W., Sornwanee S., Srichana P., Pratchyapruit W., Laisuan W. The prevalence and risk of allergic rhinitis in psoriasis patients: a systematic review and meta-analysis. Scientific Reports Vol.15 No.1 (2025). doi:10.1038/s41598-025-86779-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/108572
Title
The prevalence and risk of allergic rhinitis in psoriasis patients: a systematic review and meta-analysis
Corresponding Author(s)
Other Contributor(s)
Abstract
Psoriasis, a chronic inflammatory systemic disease, may increase the risk of allergic diseases. This meta-analysis assesses the prevalence and risk of developing allergic rhinitis in psoriasis. We systematically searched MEDLINE, Scopus, and EMBASE for population-based studies documenting AR in psoriasis compared to those without from inception to December 2023. Meta-analysis was conducted using the random-effects model. Eight studies, comprising 5 cross-sectional studies, 1 case-control study, 1 retrospective cohort study, and 1 prospective cohort study, were included. The increased prevalence of AR was 22.29% (95% CI: 0.135 to 0.281; P < 0.001; I2 = 99.05%) in the psoriasis population. The AR risk in psoriasis was insignificant (adjusted OR 1.19%; 95% CI: 0.69 to 2.06; I2 = 99%; P < 0.00001). Subgroup analysis in moderate to severe psoriasis cases revealed a trend of higher risk of AR (OR 1.41%; 95% CI: 0.94 to 2.10; I2 = 92%; P = 0.0003) with very low certainty of evidence. High heterogeneity was observed in most analyses. Our meta-analysis demonstrated a higher prevalence of AR in psoriasis patients. Evaluating and treating allergic diseases can enhance holistic treatment.